Product Reports Resources Pricing Login Book a demo

Monod Bio

Biotech & Life Sciences · Seattle, United States · Founded 2021

Develops biosensors intended for protein and other analyte detection MoreLess

Monod Bio is an innovative startup specializing in the design and development of advanced biosensors using cutting-edge protein engineering techniques. Founded in 2021 as a spin-out from the University of Washington Institute for Protein Design, the company leverages the pioneering lucCage technology developed by Dr. David Baker. This technology allows Monod Bio to create highly sensitive and specific biosensors that can detect various biological and chemical substances.

The primary clients of Monod Bio include scientists, healthcare providers, and patients. The company operates in the biotechnology and healthcare markets, focusing on applications that require precise and rapid diagnostic tools. By providing these advanced biosensors, Monod Bio aims to improve the accuracy and efficiency of diagnostic processes, ultimately benefiting patient care and scientific research.

Monod Bio's business model revolves around the development and commercialization of its biosensor technology. The company generates revenue through partnerships with corporate entities interested in integrating these biosensors into their products and services. Additionally, Monod Bio may license its technology to other companies, providing another revenue stream.

The company's biosensor platform is based on de novo protein design, which involves creating new proteins from scratch using computational methods. These proteins act as nanoswitches that can detect specific molecules and trigger a measurable response. This approach allows for the creation of highly modular and customizable biosensors that are both rapid and cost-effective.

Monod Bio's commitment to innovation and excellence is reflected in its diverse and experienced team, which combines scientific expertise with entrepreneurial and business acumen. The company is also dedicated to fostering an inclusive and supportive work environment, valuing the unique perspectives and backgrounds of its employees.

Keywords: biosensors, protein design, biotechnology, healthcare, diagnostics, lucCage technology, nanoswitches, computational engineering, innovation, partnerships.

Company overview

Monod Bio company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2021
Headquarters
Seattle, United States
Employees
27
Open positions
None listed
Dealroom signal
71.6
client focusb2bsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorSpinoutsectorBiotech and PharmasectorHard TechsectorproteomicssectorDT and LSsectorscience-based

Valuation & funding

Monod Bio funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Oct 2025 $750K Bill & Melinda Gates Foundation
GRANTOther financing Sep 2025 $1.5M Bill & Melinda Gates Foundation
SEEDEquity / VC Aug 2022 $25M $100M Cercano Management · Global Health Investment Corporation · WRF Capital · Boom Capital Ventures
SEEDEquity / VC Dec 2021 $6M $24M Undisclosed
SPINOUTOther financing Jan 2021 University of Washington · University of Washington Institute for Protein Design
Showing 5 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 28
2025 31
2024 29
2023 35
2022 26
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Monod Bio website traffic

Latest recorded traffic for Monod Bio is 2.9K monthly website visits, down 19.4% over the last three months. Monod Bio's team declined 12.9% over the past year.

Latest monthly visits2.9K 3-month web change-19.4% 1-year team growth-12.9%
Monthly website visits37 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Monod Bio compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Monod Bio's talent

Book a demo to see the people
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Monod Bio's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 8 investors entered at this stage
Matrix Capital Management
Cercano Management
Global Health Investment Corporation
WRF Capital
Boom Capital Ventures
Sahsen Ventures
Pack Ventures
Bill & Melinda Gates Foundation
Other known 3 additional known investors
University of Washington
University of Washington Institute for Protein Design
Celestine Schnugg

Global footprint

Where Monod Bio has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Monod Bio

Recent press, funding announcements, and product moves mentioning Monod Bio — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Monod Bio

An AI-synthesized read of the highest-engagement posts about Monod Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Monod Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.